Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial
暂无分享,去创建一个
P. Serruys | G. Stone | J. Sabik | D. Cohen | A. Kappetein | E. Magnuson | Khaja M. Chinnakondepalli | K. Vilain | Katherine A. Vilain
[1] P. Serruys,et al. PCI or CABG for Left Main Coronary Artery Disease. Reply. , 2020, The New England journal of medicine.
[2] M. Jeong,et al. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study. , 2015, Journal of the American College of Cardiology.
[3] P. Serruys,et al. Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial , 2014, Circulation.
[4] G. Fonarow,et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Circulation.
[5] Lynn A. Sleeper,et al. Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial , 2013, Circulation.
[6] G. Schuler,et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. , 2011, Journal of the American College of Cardiology.
[7] M. Tendera,et al. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. , 2009, Journal of the American College of Cardiology.
[8] P. Serruys,et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[9] Andrew R Willan,et al. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. , 2005, American heart journal.
[10] Stephen Joel Coons,et al. US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.
[11] Anastasios A. Tsiatis,et al. Estimating medical costs with censored data , 2000 .
[12] B. Efron. Better Bootstrap Confidence Intervals , 1987 .